Find your favorite nonprofit or choose one that inspires you from our database of over 2 million charitable organizations.
Displaying 61–72 of 94
Basic Health International exists to eliminate cervical cancer on a global level through cutting edge research for the prevention and treatment of cervical cancer in low resource settings. Through research and field-work in Latin American countries, BHI is creating a scalable blueprint of sustainable strategies that can be applied in communities throughout the world to prevent, identify, and treat cervical cancer. Aligned with the World Health Organization’s mission to eliminate cervical cancer globally by 2030, BHI’s team of experts focuses on research, community education, outreach, and policy. During COVID-19 we are building laboratory infrastructure for SARS-CoV-2 testing which can later be used for the HPV testing critical to cervical cancer elimination.
THE GOG FOUNDATION, INC. (GOG FOUNDATION) IS A NONPROFIT ORGANIZATION WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES, INCLUDING CANCERS THAT ARISE FROM THE OVARIES, UTERUS, CERVIX, VAGINA, AND VULVA. OUR INSTITUTIONS AND INVESTIGATORS ARE ESSENTIAL CONTRIBUTORS TO ADVANCEMENTS IN TREATMENT REGIMENS, SURGICAL PROCEDURES, QUALITY OF LIFE ANALYSES, AND PREVENTION KNOWLEDGE. THE RESULTS OF GOG FOUNDATION CLINICAL TRIALS HAVE INFLUENCED THE STANDARD OF CARE FOR NUMEROUS MALIGNANT GYNECOLOGIC NEOPLASMS. THE MISSION OF THE GOG FOUNDATION IS TO CONDUCT CLINICAL AND TRANSLATIONAL RESEARCH THAT POSITIVELY IMPACTS WOMEN THROUGH THE PREVENTION AND TREATMENT OF GYNECOLOGIC MALIGNANCIES. THE VISION OF THE GOG FOUNDATION IS TO BE THE PREMIER COLLABORATIVE NETWORK FOR TRANSFORMATIVE RESEARCH IN GYNECOLOGIC MALIGNANCIES.
Facilitating communication and dissemination of knowledge among scientists and others dedicated to the cancer problem; fostering research in cancer and related biomedical sciences; encouraging presentation and discussion of new and important observations in the field; providing training and public education; and advancing the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.
The Society of Gynecologic Oncology’s (SGO) Foundation for Women’s Cancer is dedicated to increasing public awareness of gynecologic cancer risk awareness, prevention, early detection and optimal treatment. Founded by SGO in 1991, the Foundation for Women’s Cancer is a nonprofit organization that also provides funding for gynecologic cancer research and training, as well as educational programs and resources.
Bright Pink helps to save lives from breast and ovarian cancer by empowering women to know their risk and manage their health proactively. We focus on health, not cancer, to inspire women to practice prevention. Our innovative programs, strategic initiatives and powerful partnerships directly reach women in their daily lives and healthcare providers in their daily practice.
Our mission is to serve and provide resources to underserved and underinsured individuals and families. We are committed to educating and navigating them through issues surrounding Preventive Care, Pre- and Post- Breast Cancer diagnoses and all aspects of Breast Health. Our vision is an end to Breast Cancer related deaths caused by late stage Breast Cancer diagnoses.
The mission of the Head and Neck Cancer Alliance is to provide hope and support to individuals impacted by head and neck cancer, to raise awareness about prevention and early detection, and to advocate for improved patient outcomes. HNC Alliance accomplishes this mission through the following strategies:Comprehensive educational resources Patient and caregiver support and navigation Community connectionsPublic awareness-raising and advocacy
The National Foundation for Cancer Research (NFCR) was founded in 1973 to support cancer research and public education relating to the prevention, early diagnosis, better treatments and, ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Making Cures Possible – cures for all types of cancer.
The mission of the Children’s Oncology Group (COG) is to cure and prevent childhood and adolescent cancer through scientific discovery and compassionate care. The Children's Oncology Group Foundation enables COG's leadership, comprised of a team of doctors, nurses, laboratory scientists and other allied professionals, the ability to direct the resources raised for childhood cancer research to the areas of highest need and opportunity.
The mission of FCRE is to devrease the death rate from cancer while enhancing patient quality of life. Our focus on prostate cancer research is a model for the treatment of other cancers and can reduce the frequency of heart attacks and strokes Our efforts in education are to acquaint the general pbulic, cancer patients, and health care professionals with recent advances in prevention, diagnosis, and treatment of prostate cancer
TO MAKE LOCALLY AVAILABLE THE HIGHEST QUALITY, STATE-OF-THE-ART RADIATION THERAPY SERVICES TO PERSONS WITH CANCER WITHIN THE BISMARCK SERVICE AREA. SUCH SERVICES SHALL BE DELIVERED, IN SO FAR AS POSSIBLE, WITHOUT REGARD TO REIMBUREMENT, AND ALWAYS IN A SUPPORTIVE, COMPASSIONATE, AND CARING MANNER, AND WILL INCLUDE NEEDED WRAP-AROUND SERVICES TO BOTH PATIENTS AND THEIR FAMILIES, EDUCATIONAL SERVICES, PREVENTION AND EARLY DETECTION INITIATIVES, AND SURVIVORSHIP PROGRAMS.
We connect breast cancer researchers, patients, and supporters together through funding for cutting-edge research, survivorship programs, and ongoing education. Our mission is to further the research, treatment, and prevention of breast cancer while strengthening and supporting patients as they navigate the complexities of their breast cancer journey. We foster collaboration for both medical research teams and breast cancer patients to share experiences, build on each other’s advances, and ultimately improve outcomes.